Retatrutude 16mg/30mg

Retatrutide 16mg/30mg — Research Grade

Retatrutide is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. It is studied for its broad metabolic effects, including enhanced fat oxidation, improved glucose regulation, and energy expenditure modulation. This product is supplied in lyophilized (powder) form and is intended strictly for in vitro and laboratory research purposes.

Key Research Areas

• Triple receptor agonism (GLP-1 / GIP / glucagon)
• Visceral and subcutaneous fat metabolism
• Glucose control and pancreatic beta-cell function
• Energy homeostasis and thermogenesis
• Obesity and metabolic disease research

Product Details

• Concentration: 16mg / 30mg
• Purity: Research grade
• Format: Lyophilized powder
• Storage: Store at -20°C; protect from light and moisture
• Reconstitution: Recommended with bacteriostatic water

For research use only. Not intended for human or veterinary use. This product has not been evaluated by the FDA and is not approved for therapeutic or diagnostic use.